322 related articles for article (PubMed ID: 3081256)
1. Inhibitors of purine nucleoside phosphorylase: effects of 9-deazapurine ribonucleosides and synthesis of 5'-deoxy-5'-iodo-9-deazainosine.
Stoeckler JD; Ryden JB; Parks RE; Chu MY; Lim MI; Ren WY; Klein RS
Cancer Res; 1986 Apr; 46(4 Pt 1):1774-8. PubMed ID: 3081256
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of 2'-deoxyguanosine cytotoxicity by a novel inhibitor of purine nucleoside phosphorylase, 8-amino-9-benzylguanine.
Shewach DS; Chern JW; Pillote KE; Townsend LB; Daddona PE
Cancer Res; 1986 Feb; 46(2):519-23. PubMed ID: 3079664
[TBL] [Abstract][Full Text] [Related]
3. Purine nucleoside phosphorylase inhibitors: biochemical and pharmacological studies with 9-benzyl-9-deazaguanine and related compounds.
Bennett LL; Allan PW; Noker PE; Rose LM; Niwas S; Montgomery JA; Erion MD
J Pharmacol Exp Ther; 1993 Aug; 266(2):707-14. PubMed ID: 8355201
[TBL] [Abstract][Full Text] [Related]
4. Design of purine nucleoside phosphorylase inhibitors.
Stoeckler JD; Ealick SE; Bugg CE; Parks RE
Fed Proc; 1986 Nov; 45(12):2773-8. PubMed ID: 3095150
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts.
Kazmers IS; Mitchell BS; Dadonna PE; Wotring LL; Townsend LB; Kelley WN
Science; 1981 Dec; 214(4525):1137-9. PubMed ID: 6795718
[TBL] [Abstract][Full Text] [Related]
6. Nucleosides. 5. Synthesis of guanine and formycin B derivatives as potential inhibitors of purine nucleoside phosphorylase.
Chern JW; Lee HY; Chen CS; Shewach DS; Daddona PE; Townsend LB
J Med Chem; 1993 Apr; 36(8):1024-31. PubMed ID: 8478902
[TBL] [Abstract][Full Text] [Related]
7. Decreased methionine synthesis in purine nucleoside-treated T and B lymphoblasts and reversal by homocysteine.
Boss GR; Pilz RB
J Clin Invest; 1984 Oct; 74(4):1262-8. PubMed ID: 6332827
[TBL] [Abstract][Full Text] [Related]
8. Potential use of purine nucleosides and enzyme inhibitors for selective depletion of Thy-lymphoblasts from human bone marrow.
Russell NH; Hoffbrand AV; Bellingham AJ
Leuk Res; 1986; 10(3):325-9. PubMed ID: 3081767
[TBL] [Abstract][Full Text] [Related]
9. An in vivo and in vitro evaluation of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine: an inhibitor of human lymphoblast purine nucleoside phosphorylase.
Willis RC; Robins RK; Seegmiller JE
Mol Pharmacol; 1980 Sep; 18(2):287-95. PubMed ID: 6106888
[No Abstract] [Full Text] [Related]
10. 7-Deazapurine 2'-deoxyribofuranosides are noncleavable competitive inhibitors of Escherichia coli purine nucleoside phosphorylase (PNP).
Bzowska A; Kazimierczuk Z; Seela F
Acta Biochim Pol; 1998; 45(3):755-68. PubMed ID: 9918502
[TBL] [Abstract][Full Text] [Related]
11. 8-Aza-immucillins as transition-state analogue inhibitors of purine nucleoside phosphorylase and nucleoside hydrolases.
Evans GB; Furneaux RH; Gainsford GJ; Hanson JC; Kicska GA; Sauve AA; Schramm VL; Tyler PC
J Med Chem; 2003 Jan; 46(1):155-60. PubMed ID: 12502369
[TBL] [Abstract][Full Text] [Related]
12. [Regulatory mutants for the synthesis of a 2d purine nucleoside phosphorylase in Escherichia coli K-12. I. Synthesis inducers and the substrate specificity of purine nucleoside phosphorylase in pndR mutants].
Kocharian ShM; Kocharian AM; Melkumian MA; Bezirdzhian KhO; Akopian ZhI
Genetika; 1984 Sep; 20(9):1463-71. PubMed ID: 6437906
[TBL] [Abstract][Full Text] [Related]
13. 8-Amino-9-substituted guanines: potent purine nucleoside phosphorylase (PNP) inhibitors.
Sircar JC; Kostlan CR; Pinter GW; Suto MJ; Bobovski TP; Capiris T; Schwender CF; Dong MK; Scott ME; Bennett MK
Agents Actions; 1987 Aug; 21(3-4):253-6. PubMed ID: 3120506
[TBL] [Abstract][Full Text] [Related]
14. [Some inhibitors of purine nucleoside phosphorylase].
Pogosian LG; Nersesova LS; Gazariants MG; Mkrtchian ZS; Akopian ZhI
Biomed Khim; 2011; 57(5):526-34. PubMed ID: 22629603
[TBL] [Abstract][Full Text] [Related]
15. Preliminary report on 8-amino-9-(2-thienylmethyl)guanine (PD 119,229), a novel and potent purine nucleoside phosphorylase inhibitor.
Gilbertsen RB; Scott ME; Dong MK; Kossarek LM; Bennett MK; Schrier DJ; Sircar JC
Agents Actions; 1987 Aug; 21(3-4):272-4. PubMed ID: 3120507
[TBL] [Abstract][Full Text] [Related]
16. Selective toxicity of purine nucleosides to human leukaemic cells.
Piga A; Ganeshaguru K; Green ES; Sheridan B; Hoffbrand AV
Adv Exp Med Biol; 1989; 253B():291-8. PubMed ID: 2514591
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of purine nucleoside phosphorylase, C(8) and C(5') substitutions.
Stoeckler JD; Cambor C; Kuhns V; Chu SH; Parks RE
Biochem Pharmacol; 1982 Jan; 31(2):163-71. PubMed ID: 6800381
[No Abstract] [Full Text] [Related]
18. Human erythrocytic purine nucleoside phosphorylase: reaction with sugar-modified nucleoside substrates.
Stoeckler JD; Cambor C; Parks RE
Biochemistry; 1980 Jan; 19(1):102-7. PubMed ID: 6766310
[TBL] [Abstract][Full Text] [Related]
19. One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.
Miles RW; Tyler PC; Furneaux RH; Bagdassarian CK; Schramm VL
Biochemistry; 1998 Jun; 37(24):8615-21. PubMed ID: 9628722
[TBL] [Abstract][Full Text] [Related]
20. Purine nucleoside phosphorylase deficiency: a molecular model for selective loss of T cell function.
Ochs UH; Chen SH; Ochs HD; Osborne WR; Scott CR
J Immunol; 1979 Jun; 122(6):2424-9. PubMed ID: 109531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
